BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 10626249)

  • 1. Expression and function of Fas during differentiation and activation of B cells.
    Wang J; Watanabe T
    Int Rev Immunol; 1999; 18(4):367-79. PubMed ID: 10626249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expansion or elimination of B cells in vivo: dual roles for CD40- and Fas (CD95)-ligands modulated by the B cell antigen receptor.
    Rathmell JC; Townsend SE; Xu JC; Flavell RA; Goodnow CC
    Cell; 1996 Oct; 87(2):319-29. PubMed ID: 8861915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Fas antigen and Fas-mediated apoptosis in B-cell differentiation.
    Akagi T; Yoshino T; Kondo E
    Leuk Lymphoma; 1998 Feb; 28(5-6):483-9. PubMed ID: 9613977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway.
    Schattner EJ; Elkon KB; Yoo DH; Tumang J; Krammer PH; Crow MK; Friedman SM
    J Exp Med; 1995 Nov; 182(5):1557-65. PubMed ID: 7595225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of bcl-xL expression and Fas susceptibility in mouse B cells by CD40 ligation, surface IgM crosslinking and IL-4.
    Koizumi T; Wang J; Suzuki Y; Masuda K; Watanabe T
    Mol Immunol; 1996 Nov; 33(16):1247-53. PubMed ID: 9129161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why do defects in the Fas-Fas ligand system cause autoimmunity?
    Suda T; Nagata S
    J Allergy Clin Immunol; 1997 Dec; 100(6 Pt 2):S97-101. PubMed ID: 9440553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerant B lymphocytes acquire resistance to Fas-mediated apoptosis after treatment with interleukin 4 but not after treatment with specific antigen unless a surface immunoglobulin threshold is exceeded.
    Foote LC; Marshak-Rothstein A; Rothstein TL
    J Exp Med; 1998 Mar; 187(6):847-53. PubMed ID: 9500787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the role and significance of Fas (Apo-1/CD95) ligand (FasL) expression in immune privileged tissues and cancer cells using multiple myeloma as a model.
    Greil R; Egle A; Villunger A
    Leuk Lymphoma; 1998 Nov; 31(5-6):477-90. PubMed ID: 9922038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fas ligation induces apoptosis of CD40-activated human B lymphocytes.
    Garrone P; Neidhardt EM; Garcia E; Galibert L; van Kooten C; Banchereau J
    J Exp Med; 1995 Nov; 182(5):1265-73. PubMed ID: 7595197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid B cell apoptosis induced by antigen receptor ligation does not require Fas (CD95/APO-1), the adaptor protein FADD/MORT1 or CrmA-sensitive caspases but is defective in both MRL-+/+ and MRL-lpr/lpr mice.
    Yoshida T; Higuchi T; Hagiyama H; Strasser A; Nishioka K; Tsubata T
    Int Immunol; 2000 Apr; 12(4):517-26. PubMed ID: 10744653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular and cellular mechanisms regulating T and B cell apoptosis through Fas/FasL interaction.
    Ju ST; Matsui K; Ozdemirli M
    Int Rev Immunol; 1999; 18(5-6):485-513. PubMed ID: 10672498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repression of B7.2 on self-reactive B cells is essential to prevent proliferation and allow Fas-mediated deletion by CD4(+) T cells.
    Rathmell JC; Fournier S; Weintraub BC; Allison JP; Goodnow CC
    J Exp Med; 1998 Aug; 188(4):651-9. PubMed ID: 9705947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4+ T-cell induction of Fas-mediated apoptosis in Burkitt's lymphoma B cells.
    Schattner EJ; Mascarenhas J; Bishop J; Yoo DH; Chadburn A; Crow MK; Friedman SM
    Blood; 1996 Aug; 88(4):1375-82. PubMed ID: 8695856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mature but not immature Fas ligand (CD95L)-transduced human monocyte-derived dendritic cells are protected from Fas-mediated apoptosis and can be used as killer APC.
    Hoves S; Krause SW; Halbritter D; Zhang HG; Mountz JD; Schölmerich J; Fleck M
    J Immunol; 2003 Jun; 170(11):5406-13. PubMed ID: 12759415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation mediated by RP105 but not CD40 makes normal B cells susceptible to anti-IgM-induced apoptosis: a role for Fc receptor coligation.
    Yamashita Y; Miyake K; Miura Y; Kaneko Y; Yagita H; Suda T; Nagata S; Nomura J; Sakaguchi N; Kimoto M
    J Exp Med; 1996 Jul; 184(1):113-20. PubMed ID: 8691124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligation of CD40 potentiates Fas-mediated activation of the cysteine protease CPP32, cleavage of its death substrate PARP, and apoptosis in Ramos-Burkitt lymphoma B cells.
    An S; Yap D; Knox KA
    Cell Immunol; 1997 Nov; 181(2):139-52. PubMed ID: 9398401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the Fas death pathway by FLICE-inhibitory protein in primary human B cells.
    Hennino A; Berard M; Casamayor-Pallejà M; Krammer PH; Defrance T
    J Immunol; 2000 Sep; 165(6):3023-30. PubMed ID: 10975811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of complement-binding CD21/CD19/CD81 in enhancing human B cell protection from Fas-mediated apoptosis.
    Mongini PK; Jackson AE; Tolani S; Fattah RJ; Inman JK
    J Immunol; 2003 Nov; 171(10):5244-54. PubMed ID: 14607925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD95/Fas-triggered apoptosis of activated T lymphocytes is prevented by dendritic cells through a CD58-dependent mechanism.
    Daniel PT; Scholz C; Essmann F; Westermann J; Pezzutto A; Dörken B
    Exp Hematol; 1999 Sep; 27(9):1402-8. PubMed ID: 10480431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Fas-mediated apoptosis by antigen: implications for lymphomagenesis.
    Schattner EJ; Friedman SM; Casali P
    Autoimmunity; 2002 Jul; 35(4):283-9. PubMed ID: 12482198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.